Hepatic enzymes' level during chronic use of anticonvulsant drugs
Hoshino, Mauricio; Heise, Carlos Otto; Puglia, Paulo; Almeida, Arlete B. B; Cukiert, Arthur.
Arq. neuropsiquiatr
; 53(4): 719-23, dez. 1995. graf
Artículo en Inglés | LILACS | ID: lil-161574
Documentos relacionados
Effects of Sodium Valproate Monotherapy on Blood Liver Enzyme Levels in Patients with Epilepsy: A Meta-Analysis.
A review on epilepsy, current treatments, and potential of medicinal plants as an alternative treatment.
The association of ABCB1 gene polymorphism with clinical response to carbamazepine monotherapy in patients with epilepsy.
Improving antiepileptic drug tolerability among patients living with epilepsy: the impact of pharmaceutical care services.
Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper.
Reduction in anti-seizure medications use in pediatric patients with pharmacoresistant epilepsy submitted to surgical treatment.
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
Efficacy and safety of adjunctive treatment with perampanel in epilepsy patients.
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management.
Therapeutic drug monitoring in pregnancy: Levetiracetam.